Morgan Stanley Opens Crypto Trading Gates: Bitcoin, Ethereum, and Solana Now Available on E*TRADE
Morgan Stanley just dropped a major expansion into crypto trading—eligible customers can now buy, sell, and hold Bitcoin, Ethereum, and Solana directly through ETRADE, the firm's retail brokerage platform. The move runs through a partnership with Zero Hash, a crypto infrastructure provider handlin

Morgan Stanley just dropped a major expansion into crypto trading—eligible customers can now buy, sell, and hold Bitcoin, Ethereum, and Solana directly through E*TRADE, the firm's retail brokerage platform. The move runs through a partnership with Zero Hash, a crypto infrastructure provider handling the backend operations.
What's Actually Changing for Retail Investors
This isn't some niche offering buried in a legacy system. We're talking about crypto trading integrated into one of Wall Street's most accessible platforms. E*TRADE customers meeting Morgan Stanley's eligibility criteria can now manage Bitcoin, Ethereum, and Solana positions alongside their traditional equities and ETFs. That's a significant shift for a firm that was cautious about retail crypto exposure just a few years ago.
The Zero Hash partnership is the real infrastructure play here. Instead of building everything in-house, Morgan Stanley leveraged an existing crypto trading and settlement specialist. That's smart capital allocation—get the pieces in place through proven partners rather than reinventing the wheel. Zero Hash handles custody, settlement, and the underlying execution, while Morgan Stanley manages client relationships and regulatory compliance.
Why This Matters for the Broader Market
Morgan Stanley's move signals something important: Wall Street isn't just tolerating crypto anymore—major institutions are actively building it into their core retail offerings. This follows other institutional players expanding their crypto capabilities. The fact that it's available on E*TRADE, a platform used by millions of retail traders, means we're looking at potential liquidity influx into these three assets.
Bitcoin and Ethereum are the obvious plays—they're the most established and have regulatory clarity. But Solana's inclusion is noteworthy. It signals confidence in layer-one blockchain alternatives and positions Solana as a top-tier crypto asset worthy of institutional-grade infrastructure.
The Eligibility Question
One detail worth watching: Morgan Stanley limited this to "eligible customers." That means there's a screening process. The firm isn't opening crypto trading to every E*TRADE account holder. Restrictions likely involve account minimums, suitability assessments, or accreditation requirements. This is typical for Wall Street—crypto adoption with guardrails.
What Traders Should Watch
The expansion matters for market intelligence. Institutional-grade infrastructure reaching retail users typically increases trading volume and price discovery. We're seeing a trend where crypto's barriers to entry keep lowering for mainstream investors. When a platform with millions of users adds Bitcoin, Ethereum, and Solana trading, you're looking at potential new capital flows into these assets.
The integration also matters for portfolio construction. Crypto holdings that can sit alongside traditional assets in one account reduce friction for traders building diversified positions. That's the real game—making crypto not a special asset class, but a normal component of a modern portfolio.
Alpha Take
Morgan Stanley's E*TRADE crypto expansion accelerates institutional legitimacy for Bitcoin, Ethereum, and Solana. The Zero Hash partnership demonstrates how legacy finance and crypto infrastructure are converging. Watch for similar announcements from other major brokers—once one player moves, competitive pressure typically forces others to follow. This is bullish for mainstream crypto adoption and trading volume.
Originally reported by
Decrypt
Not financial advice. Crypto investing involves significant risk. Past performance does not guarantee future results. Always do your own research.